(800) 846-1279 | fax: 855-385-7969

We’re passionate about keeping cardiopulmonary providers up-to-date with industry information and inspiration. 



The 6MWT is a useful measure of functional capacity targeted at people with at least moderately severe impairment. The test has been widely used for preoperative and postoperative evaluation and for measuring the response to therapeutic interventions for pulmonary and cardiac disease.

Cardiac Rehab and Secondary Prevention programs are becoming increasingly involved in the comprehensive care of patients with heart failure. This one-page guide utilizes the FITT Principle to prescribe a safe and beneficial exercise training program in order to achieve optimal outcomes for patients with heart failure.

WHITEPAPER By Dr. Carl N. King
Chronic Heart Failure is the most common cause of hospitalization for CMS patients and it is the only cardiovascular diagnosis that is increasing in prevalence. As the US population ages, the trend will continue through 2029. This paper is written to assist cardiac rehabilitation professionals by explaining the role of cardiac rehabilitation programs in treating patients with Chronic Heart Failure.

Tracking and measuring patient outcomes continues to play an increasingly important role in cardiopulmonary rehab certification, quality measurement and insurance reimbursements. However, it can be difficult for programs to know how to begin tracking and where to focus improvement efforts. We’ve created this guide to help programs that are beginning to integrate outcomes tracking into their clinical documentation process. For programs that already track outcomes, we hope this guide will provide ideas from improving and expanding current efforts.

WHITEPAPER By: Dr. Carl N. King
Blood pressure (BP), both systolic (SBP) and diastolic (DBP), is the most variable physiological measurement that we routinely check in cardiac rehabilitation. This paper is written to assist cardiac rehabilitation professionals to better determine when and where a BP might be most appropriate. As is the case with all individualized treatment plans, patient status (including history and physical exam by the referring physician) as well as the results from the exercise assessment (prior to entering cardiac rehabilitation) must be considered.

WHITEPAPER By: Dr. Carl N. King
Development of an individualized, personalized exercise prescription is the cornerstone of comprehensive cardiac rehabilitation. An exercise assessment must precede the implementation of an exercise program for all cardiac patients who are enrolling in a cardiac rehabilitation program. This paper is written to assist cardiac rehabilitation professionals by explaining how functional exercise tests can be used to develop a better cardiac rehabilitation program.

WHITEPAPER By: Dr. Carl N. King
The need to measure functional capacity and write an individualized exercise prescription in cardiac rehabilitation patients prior to beginning a Cardiac Rehabilitation Program has been grossly underutilized over the last decade. A simple, but valid and reliable test, might make this evaluation and prescription possible. The approved King 6-Minute Cycle Test (6 MC) was previously validated and the reliability established when compared to the American Thoracic Society (ATS) 6-Minute Walk Test.

WHITEPAPER By: Dr. Carl N. King
Peripheral Arterial Disease (PAD) is a prevalent but under-diagnosed atherosclerotic vascular disorder that is estimated to impact 8-12 million people in the United States. Medicare recently approved a reimbursement payment for Supervised Exercise Therapy for PAD. Following this announcement, this paper is one in a series designed to provide an explanation of the prevalence and pathophysiology of PAD. Subsequent papers will present a foundation for the development and design of Supervised Exercise Therapy for PAD patients in the cardiac rehabilitation setting.

WHITEPAPER By: Dr. Carl N. King
This paper presents a foundation for the development and design of Supervised Exercise Therapy (SET) for PAD patients in the cardiac rehabilitation setting. SET has been recommended in the treatment of claudication symptoms for PAD.

Cardiac rehabilitation is increasingly recognized as an integral component of the continuum of care for patients with cardiovascular disease (CVD). Its application is a class I recommendation in most contemporary cardiovascular clinical practice guidelines. Despite documentation of the substantial benefits, including improved morbidity and mortality rates, cardiac rehabilitation (CR) services are vastly underutilized.

To request a free electronic copy of our Whitepapers and Guides, please complete the following form:









    Hospital Name *




    Zip Code*


    “LSI has been outstanding and has worked efficiently and collaboratively with all of our team members.”

    Jennifer | Orlando, Florida